Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Intraday Session

Author: Benzinga Insights | March 23, 2023 01:31pm

Gainers

  • ZyVersa Therapeutics (NASDAQ:ZVSA) shares increased by 31.4% to $2.14 during Thursday's regular session. As of 13:30 EST, this security is trading at a volume of 8.9 million shares, making up 2630.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $19.7 million.
  • Jaguar Health (NASDAQ:JAGX) shares increased by 25.92% to $1.02. The current volume of 3.2 million shares is 317.5% of Jaguar Health's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $2.0 million.
  • Erytech Pharma (NASDAQ:ERYP) stock moved upwards by 24.95% to $0.99. The company's market cap stands at $30.7 million.
  • HTG Molecular Diagnostics (NASDAQ:HTGM) stock increased by 24.81% to $3.42. Trading volume for HTG Molecular Diagnostics's stock is 332.9K as of 13:30 EST. This is 47.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.4 million.
  • Generation Bio (NASDAQ:GBIO) shares rose 24.74% to $4.84. Trading volume for this security as of 13:30 EST is 10.4 million, which is 4906.8% of its average full-day volume over the last 100 days. The company's market cap stands at $288.7 million.
  • scPharmaceuticals (NASDAQ:SCPH) stock rose 23.98% to $8.58. As of 13:30 EST, scPharmaceuticals's stock is trading at a volume of 602.6K, which is 119.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $292.1 million. As per the news, the Q4 earnings report came out yesterday.

Losers

  • Vicarious Surgical (NYSE:RBOT) stock fell 32.5% to $1.53 during Thursday's regular session. As of 13:30 EST, this security is trading at a volume of 3.3 million shares, making up 1178.6% of its average full-day volume over the last 100 days. The company's market cap stands at $193.0 million.
  • Surrozen (NASDAQ:SRZN) stock declined by 23.44% to $0.76. As of 13:30 EST, this security is trading at a volume of 634.1K shares, making up 91.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $22.5 million. As per the news, the Q4 earnings report came out yesterday.
  • Avrobio (NASDAQ:AVRO) stock fell 22.16% to $0.96. Trading volume for this security as of 13:30 EST is 879.9K, which is 69.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $41.9 million. As per the press release, Q4 earnings came out today.
  • Cidara Therapeutics (NASDAQ:CDTX) stock fell 20.79% to $1.5. As of 13:30 EST, this security is trading at a volume of 8.8 million shares, making up 315.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $124.4 million. The company's, Q4 earnings came out today.
  • SenesTech (NASDAQ:SNES) shares declined by 19.15% to $1.52. SenesTech's stock is trading at a volume of 193.0K shares as of 13:30 EST. This is 109.4% of its average full-day volume over the last 100 days. The company's market cap stands at $3.1 million.
  • Marker Therapeutics (NASDAQ:MRKR) stock fell 18.35% to $0.98. The current volume of 231.4K shares is 526.3% of Marker Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $8.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AVRO CDTX ERYP GBIO HTGM JAGX MRKR RBOT SCPH SNES SRZN ZVSA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist